Riffyn Appoints Former Greenlots Executive, Vipul Doshi, as VP of Software Engineering
Riffyn, the leading provider of SaaS for Intelligent Process Development (IPD), today announced that Vipul Doshi, a software leader in healthcare SaaS and IoT solutions, has been appointed as Riffyn’s Vice President of Software Engineering to accelerate the next stage of the company’s growth in the IPD market.
Read More: SalesTechStar Interview with Shannon Jessup, Chief Revenue Officer at tvScientific
“It has already transformed top biopharma and industrial biotech companies who are developing life-changing products. I’m thrilled to join this talented team, and look forward to delivering exceptional user experiences to our customers through new product features and improvements.”
Vipul brings more than 25 years of software industry experience with notable success in driving breadth of cloud-hosted SaaS applications. His work at Greenlots (a Shell subsidiary) has been recognized as instrumental to the successful deployment of cloud based software for the largest fast charging electric vehicle network in North America. He brings expertise in building and leading globally distributed software engineering teams including Greenlots, Blink Network, and IGT.
Read More: Snapt Launches Nova 2 For Improved User Experience
“Riffyn’s process-centric approach to orchestrating scientific data feeds the increasing needs for better data governance and readiness for machine learning in R&D labs,” said Vipul. “It has already transformed top biopharma and industrial biotech companies who are developing life-changing products. I’m thrilled to join this talented team, and look forward to delivering exceptional user experiences to our customers through new product features and improvements.”
“Vipul’s expertise and experience in building cloud SaaS solutions, from start-ups to the large enterprises and across industries, will be invaluable to elevating Riffyn’s IPD-enabling platform to meet the accelerating demand for Riffyn Nexus in bioprocess and biotech organizations,” said Riffyn CEO Tim Gardner.
